News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

The Week in Review: Sinopharm Group's M&A Extends Drug Distribution Network


1/31/2011 9:45:46 AM

January 29, 2011 -- Sinopharm Group will pay $198 million for a 60% stake in Hubei drug distributor Le Ren Tang; Kelun Pharma will acquire 80% ownership of Guilin Dahua Pharma, an API company, for $21.9 million; Golden Meditech raised $34.7 million through a secondary listing in Taiwan; Bohai Pharma brought in $1.87 million via a private placement; China National Pharmaceutical Group (Sinopharm) will invest $200 million to build a manufacturing facility in Vietnam; Tianyin Pharma completed building an antibiotic manufacturing plant near Chengdu; BMI upped its short-term CAGR for the China pharma market to 16.4%; Boston Scientific started a China trial of its Promus™ drug eluting stent; 3SBio Inc. was granted SFDA approval for an extension of the TPIAO label; and First China Pharmaceutical Group won exclusive distributor rights for an anti-arrhythmia treatment. More details....

Read at BioSpace.com
Read at ChinaBio Today

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES